Artykuły w czasopismach na temat „MUTANT SCORE”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „MUTANT SCORE”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Xie, Yuancai, Yingmei Li, Linfeng Dong, Shifu Chen i Jixian Liu. "A differential analysis of TCR repertoire between patients with EGFR-mutant and KRAS-mutant non–small-cell lung cancer." Journal of Clinical Oncology 41, nr 16_suppl (1.06.2023): e21012-e21012. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e21012.
Pełny tekst źródłaSugave, Shounak Rushikesh, Yogesh R. Kulkarni i Balaso. "Multi-Objective Optimization Model and Hierarchical Attention Networks for Mutation Testing". International Journal of Swarm Intelligence Research 14, nr 1 (9.03.2023): 1–23. http://dx.doi.org/10.4018/ijsir.319714.
Pełny tekst źródłaKarsy, Michael, Jian Guan i L. Eric Huang. "Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase–mutant glioma". Journal of Neurosurgery 130, nr 1 (marzec 2018): 56–66. http://dx.doi.org/10.3171/2017.9.jns172036.
Pełny tekst źródłaAlmahasheer, Arwa Ali, Amal Mahmoud, Hesham El-Komy, Amany I. Alqosaibi, Sultan Aktar, Sayed AbdulAzeez i J. Francis Borgio. "Novel Feather Degrading Keratinases from Bacillus cereus Group: Biochemical, Genetic and Bioinformatics Analysis". Microorganisms 10, nr 1 (1.01.2022): 93. http://dx.doi.org/10.3390/microorganisms10010093.
Pełny tekst źródłaYu, Guangyang, Ying Pang, Mythili Merchant, Chimene Kesserwan, Vineela Gangalapudi, Abdalla Abdelmaksoud, Alice Ranjan i in. "Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse Gliomas". Cancers 13, nr 23 (3.12.2021): 6092. http://dx.doi.org/10.3390/cancers13236092.
Pełny tekst źródłaGuimarães-Souza, Nadia Karina, Liliya Marsovna Yamaleyeva, Baisong Lu, Ana Claudia Mallet de Souza Ramos, Colin Edward Bishop i Karl Erik Andersson. "Superoxide overproduction and kidney fibrosis: a new animal model". Einstein (São Paulo) 13, nr 1 (marzec 2015): 79–88. http://dx.doi.org/10.1590/s1679-45082015ao3179.
Pełny tekst źródłaYeatman, Timothy Joseph, Mingli Yang, Michael J. Schell, Andrey Loboda, Michael Nebozhyn, Jiannong Li, Jamie K. Teer, Caio Max S. Rocha Lima i Jack Pledger. "Identification of mutation biomarkers underpinning colon cancer sidedness and cetuximab sensitivity." Journal of Clinical Oncology 36, nr 4_suppl (1.02.2018): 629. http://dx.doi.org/10.1200/jco.2018.36.4_suppl.629.
Pełny tekst źródłaHe, Qiong, Yamin Li, Xihong Zhou, Wen Zhou, Chunfang Xia, Ruzhe Zhang, Zhengjie Zhang, Aiyang Hu, Siyin Peng i Jing Li. "The combination of fibrinogen concentrations and the platelet-to-lymphocyte ratio predicts survival in patients with advanced lung adenocarcinoma treated with EGFR-TKIs". Journal of International Medical Research 49, nr 4 (kwiecień 2021): 030006052110040. http://dx.doi.org/10.1177/03000605211004021.
Pełny tekst źródłaBoucai, Laura, Venkatraman Seshan, Michelle Williams, Jeffrey A. Knauf, Mahesh Saqcena, Ronald A. Ghossein i James A. Fagin. "Characterization of Subtypes of BRAF-Mutant Papillary Thyroid Cancer Defined by Their Thyroid Differentiation Score". Journal of Clinical Endocrinology & Metabolism 107, nr 4 (23.11.2021): 1030–39. http://dx.doi.org/10.1210/clinem/dgab851.
Pełny tekst źródłaHannaway, Nicola, Stefania Kassaris, Janine Marie Davies, Alannah Smrke, Anna Tinker i Yvette Drew. "Using chemotherapy response by KELIM score to predict response to first line maintenance PARP inhibitor therapy in non-BRCA mutant/homologous recombination deficiency (HRD) unknown high grade serous ovarian cancer (HGSOC)." Journal of Clinical Oncology 41, nr 16_suppl (1.06.2023): e17547-e17547. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e17547.
Pełny tekst źródłaSaw, Stephanie, Gillianne Lai, Aaron C. Tan, Siqin Zhou, Mei-Kim Ang, Wan-Teck Lim, Ravindran Kanesvaran i in. "PD-L1 score as a prognostic biomarker in Asian patients with early-stage, EGFR-mutated lung cancer." Journal of Clinical Oncology 40, nr 16_suppl (1.06.2022): 8527. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.8527.
Pełny tekst źródłaDelorenzi, Mauro, Sarah Gerster, Josep Tabernero, Claus-Henning Köhne, Peter J. O'Dwyer, Alberto F. Sobrero, Eric van Cutsem i in. "Microarray gene expression study of the RESPECT trial for the identification of prognostic and predictive markers." Journal of Clinical Oncology 31, nr 15_suppl (20.05.2013): e14561-e14561. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e14561.
Pełny tekst źródłaMontégut, Coline, Jean-Sébastien Guillamo, François Ducray, Caroline Dehais, Cohen-Jonathan Moyal Elisabeth, Christine Desenclos, Antoine Petit i in. "NCOG-09. PREDICTIVE GERIATRIC FACTORS IN ELDERLY PATIENTS TREATED FOR IDH-MUTANT HIGH-GRADE GLIOMAS: A FRENCH POLA NETWORK STUDY". Neuro-Oncology 23, Supplement_6 (2.11.2021): vi153. http://dx.doi.org/10.1093/neuonc/noab196.600.
Pełny tekst źródłaMiyawaki, Eriko, Haruyasu Murakami, Keita Mori, Nobuaki Mamesaya, Takahisa Kawamura, Haruki Kobayashi, Shota Omori i in. "PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancer". Japanese Journal of Clinical Oncology 50, nr 5 (25.03.2020): 617–22. http://dx.doi.org/10.1093/jjco/hyaa033.
Pełny tekst źródłaAdderley, Helen M., Mihaela Aldea, Jaqueline Aredo, Mathew Carter, Matthew Church, Pantelis Nicola, Jamie Weaver i in. "Abstract 2975: RAS precision medicine transatlantic partnership: Exploration of RAS and NF1 co-mutations in NSCLC". Cancer Research 82, nr 12_Supplement (15.06.2022): 2975. http://dx.doi.org/10.1158/1538-7445.am2022-2975.
Pełny tekst źródłaMasoodi, Tariq Ahmad, Sulaiman A. Al Shammari, May N. Al-Muammar i Adel A. Alhamdan. "Screening and Evaluation of Deleterious SNPs in APOE Gene of Alzheimer’s Disease". Neurology Research International 2012 (2012): 1–8. http://dx.doi.org/10.1155/2012/480609.
Pełny tekst źródłaPoon, CC, P. Gordon, K. Liu, R. Yang, S. Sarkar, VW Yong i J. Kelly. "GP.06 Differential microglia and macrophage profiles in human IDH-mutant and -wildtype glioblastoma reveal therapeutic vulnerabilities". Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 46, s1 (czerwiec 2019): S7. http://dx.doi.org/10.1017/cjn.2019.82.
Pełny tekst źródłaHide, Takuichiro, Jun Hatakeyama, Chiharu Kimura-Yoshida, E. Tian, Naoki Takeda, Yukitaka Ushio, Toshihiko Shiroishi, Shinichi Aizawa i Isao Matsuo. "Genetic modifiers of otocephalic phenotypes inOtx2heterozygous mutant mice". Development 129, nr 18 (15.09.2002): 4347–57. http://dx.doi.org/10.1242/dev.129.18.4347.
Pełny tekst źródłaOklejewicz, Małgorzata, Serge Daan, Eddy Van Der Zee i Menno Gerkema. "MEMORY RETENTION IN WILD-TYPE AND TAU MUTANT SYRIAN HAMSTERS". Behaviour 138, nr 6 (2001): 789–96. http://dx.doi.org/10.1163/156853901752233415.
Pełny tekst źródłaKakar, Kifayatullah, Tran Dang Xuan, Nguyen Van Quan, Imran Khan Wafa, Hoang-Dung Tran, Tran Dang Khanh i Tran Dang Dat. "Efficacy of N-methyl-N-nitrosourea (MNU) Mutation on Enhancing the Yield and Quality of Rice". Agriculture 9, nr 10 (27.09.2019): 212. http://dx.doi.org/10.3390/agriculture9100212.
Pełny tekst źródłaYan, Dong, Lixin Sun, Jiandong Yang, Xuyang Zhang, Xia You, Tingting Sun i Chuang Qi. "Prognostic values of immune landscape in Ras-mutant colorectal cancer peritoneal metastases." Journal of Clinical Oncology 40, nr 16_suppl (1.06.2022): e15583-e15583. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e15583.
Pełny tekst źródłaYan, Dong, Lixin Sun, Jiandong Yang, Xuyang Zhang, Xia You, Tingting Sun i Chuang Qi. "Prognostic values of immune landscape in Ras-mutant colorectal cancer peritoneal metastases." Journal of Clinical Oncology 40, nr 16_suppl (1.06.2022): e15583-e15583. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e15583.
Pełny tekst źródłaDao Trong, Philip, Saskia Rösch, Heimo Mairbäurl, Stefan Pusch, Andreas Unterberg, Christel Herold-Mende i Rolf Warta. "Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma". International Journal of Molecular Sciences 19, nr 10 (25.09.2018): 2903. http://dx.doi.org/10.3390/ijms19102903.
Pełny tekst źródłaMartinez Lago, Nieves, Marta Covela Rúa, Elena Brozos, Ana Fernandez Montes, Juan de La Camara Gomez, Carlos Méndez Méndez, Mónica Jorge Fernández i Antia Cousillas Castiñeira. "The role of Systemic Inflammation Score (SIS) in BRAF(V600) mutant metastatic colorectal cancer (mCRC)." Journal of Clinical Oncology 38, nr 15_suppl (20.05.2020): e16051-e16051. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e16051.
Pełny tekst źródłaJacobsen, Ilse, Isabel Hennig-Pauka, Nina Baltes, Matthias Trost i Gerald-F. Gerlach. "Enzymes Involved in Anaerobic Respiration Appear To Play a Role in Actinobacillus pleuropneumoniae Virulence". Infection and Immunity 73, nr 1 (styczeń 2005): 226–34. http://dx.doi.org/10.1128/iai.73.1.226-234.2005.
Pełny tekst źródłaRandall, Jamie, Hongkun Wang, Sheryl Krevsky Elkin, Gail Payne, Sarah Mullaly, Erica Marchlik, Dan Barnett i in. "Targetable mutations in gastrointestinal malignancies: A comparison of RAS mutant and RAS wild type tumors." Journal of Clinical Oncology 39, nr 3_suppl (20.01.2021): 129. http://dx.doi.org/10.1200/jco.2021.39.3_suppl.129.
Pełny tekst źródłaDzambazovska-Trajkovska, Vanja, Jordan Nojkov, Andrijan Kartalov, Biljana Kuzmanovska, Tatjana Spiroska, Redzep Seljmani, Gjorgji Trajkovski, Nadica Matevska-Geshkovska i Aleksandar Dimovski. "Association of Single-Nucleotide Polymorhism C3435T in the ABCB1 Gene with Opioid Sensitivity in Treatment of Postoperative Pain". PRILOZI 37, nr 2-3 (1.11.2016): 73–80. http://dx.doi.org/10.1515/prilozi-2016-0019.
Pełny tekst źródłaBerzero, Giulia, Luisa Bellu, Capucine Baldini, François Ducray, David Guyon, Marica Eoli, Antonio Silvani i in. "Sustained Tumor Control With MAPK Inhibition in BRAF V600–Mutant Adult Glial and Glioneuronal Tumors". Neurology 97, nr 7 (4.06.2021): e673-e683. http://dx.doi.org/10.1212/wnl.0000000000012330.
Pełny tekst źródłaDorta Suarez, M., B. Jimenez Munarriz, A. Del Barrio, G. Garcia Ledo, R. Blanco Blanco, E. Conde Gallego, S. Hernandez Prieto, F. Lopez Rios i A. Cubillo Gracián. "12P Molecular features of KRAS mutant NSCLC: Weaving a future score for immune-checkpoint inhibitors (ICI)". Annals of Oncology 32 (październik 2021): S1349. http://dx.doi.org/10.1016/j.annonc.2021.08.2008.
Pełny tekst źródłaSchneider, Friederike, Annika Dufour, Tobias Benthaus, Stephanie Schneider, Gudrun Mellert, Evelyn Zellmeier, Stefan K. Bohlander i in. "A New Molecular and Clinical Prognostic Score for Risk Stratification in CN-AML." Blood 114, nr 22 (20.11.2009): 2635. http://dx.doi.org/10.1182/blood.v114.22.2635.2635.
Pełny tekst źródłaBurgess, Brian T., Abigail M. Anderson, J. Robert McCorkle, Jianrong Wu, Frederick R. Ueland i Jill M. Kolesar. "Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells". Diagnostics 10, nr 2 (22.02.2020): 121. http://dx.doi.org/10.3390/diagnostics10020121.
Pełny tekst źródłaRothermel, Luke Daniel, Mehrdad Zarei, Alexander W. Loftus, Jonathan J. Hue, Omid Hajihassani, Hallie J. Graor i Jordan Michael Winter. "A powerful drug combination strategy targeting BRAF-mutant melanoma." Journal of Clinical Oncology 41, nr 16_suppl (1.06.2023): 3152. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.3152.
Pełny tekst źródłaMoorman, Nathaniel J., Chie Yu Lin i Samuel H. Speck. "Identification of Candidate Gammaherpesvirus 68 Genes Required for Virus Replication by Signature-Tagged Transposon Mutagenesis". Journal of Virology 78, nr 19 (1.10.2004): 10282–90. http://dx.doi.org/10.1128/jvi.78.19.10282-10290.2004.
Pełny tekst źródłaTan, Lili, Yunzhan Gong i Yawen Wang. "A Model for Predicting Statement Mutation Scores". Mathematics 7, nr 9 (23.08.2019): 778. http://dx.doi.org/10.3390/math7090778.
Pełny tekst źródłaKeshtvarz, Maryam, Mahdieh Mahboobi, Marek Kieliszek, Antoni Miecznikowski, Hamid Sedighian, Milad Rezaei, Mohammad Ali Haghighi, Zahra Zareh i Ehsan Rezaei. "Engineering of Cytolethal Distending Toxin B by Its Reducing Immunogenicity and Maintaining Stability as a New Drug Candidate for Tumor Therapy; an In Silico Study". Toxins 13, nr 11 (5.11.2021): 785. http://dx.doi.org/10.3390/toxins13110785.
Pełny tekst źródłaDoubleday, Kevin, Daniel Gaile, Ravi Vijaya-Satya, Xianxian Liu, Kevin D'Auria, Soni Shukla, Han-Yu Chuang, Katie Quinn i Darya Chudova. "Abstract 5015: Precision profile simulation study for a next generation sequencing bTMB assay". Cancer Research 82, nr 12_Supplement (15.06.2022): 5015. http://dx.doi.org/10.1158/1538-7445.am2022-5015.
Pełny tekst źródłaEl Baiomy, Mohamed Ali, Salah Aref i Mohamed El-Ghonemy. "Influence of CYP3A5 and SLCO1 on Imatinib Response Among Egyptian Patients with Chronic Myeloid Leukemia in Chronic Phase". Blood 128, nr 22 (2.12.2016): 5135. http://dx.doi.org/10.1182/blood.v128.22.5135.5135.
Pełny tekst źródłaChandler, David, Sash Lopaticki, Dexing Huang, Michael Hunter, Dora Angelicheva, Trevor Kilpatrick, Rosalind HM King, Luba Kalaydjieva i Grant Morahan. "The stretcher spontaneous neurodegenerative mutation models Charcot-Marie-Tooth disease type 4D". F1000Research 2 (13.02.2013): 46. http://dx.doi.org/10.12688/f1000research.2-46.v1.
Pełny tekst źródłaRamadhan, Dwi Syah Fitra, i Daryono H. Tjahjono. "Prediksi dan Identifikasi Struktur Protein EGFR Kanker Paru dengan Mutasi Titik L718Q/T790M Secara Pemodelan Homologi In Silico". Jurnal Sains dan Kesehatan 2, nr 4 (31.12.2020): 491–96. http://dx.doi.org/10.25026/jsk.v2i4.257.
Pełny tekst źródłaJohansson, Elinn, i Alexander Pietras. "CSIG-11. HYPOXIA SIGNALING IN ACVR1-MUTANT DIFFUSE INTRINSIC PONTINE GLIOMA". Neuro-Oncology 24, Supplement_7 (1.11.2022): vii41. http://dx.doi.org/10.1093/neuonc/noac209.160.
Pełny tekst źródłaGómez-Almería, Marta, Sonia Burgaz, Carlos Costas-Insua, Carmen Rodríguez-Cueto, Irene Santos-García, Ignacio Rodríguez-Crespo, Concepción García, Manuel Guzmán, Eva de Lago i Javier Fernández-Ruiz. "BiP Heterozigosity Aggravates Pathological Deterioration in Experimental Amyotrophic Lateral Sclerosis". International Journal of Molecular Sciences 22, nr 22 (20.11.2021): 12533. http://dx.doi.org/10.3390/ijms222212533.
Pełny tekst źródłaPoojitha, T. N. S., K. V. L. Pushpanjali, D. Goutham, K. V. Yashwanth i Srinivas Prasad. "A study on mutation testing of object oriented programs". International Journal of Engineering & Technology 7, nr 1.1 (21.12.2017): 243. http://dx.doi.org/10.14419/ijet.v7i1.1.9478.
Pełny tekst źródłaDutta, Sayantanee, Gudrun Pregartner, Frank G. Rücker, Ellen Heitzer, Armin Zebisch, Lars Bullinger, Andrea Berghold, Konstanze Döhner i Heinz Sill. "Functional Classification of TP53 Mutations in Acute Myeloid Leukemia". Blood 134, Supplement_1 (13.11.2019): 2725. http://dx.doi.org/10.1182/blood-2019-124316.
Pełny tekst źródłaYabe, Mariko, Aidana Z. Omarbekova, Meier Hsu, Hannah May, Maria E. Arcila, Ying Liu, Ahmet Dogan i in. "TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes". Cancers 13, nr 21 (2.11.2021): 5502. http://dx.doi.org/10.3390/cancers13215502.
Pełny tekst źródłaWu, Dongping, Lingjuan Huang, Jiwei Mao, Jianjiang Liu, Wanli Ye, Jun Xu, Wangyan Zhong, Xiaoyu Zhang i Shenpeng Ying. "Combination of Tumor Mutational Burden and DNA Damage Repair Gene Mutations with Stromal/Immune Scores Improved Prognosis Stratification in Patients with Lung Adenocarcinoma". Journal of Oncology 2022 (20.09.2022): 1–12. http://dx.doi.org/10.1155/2022/6407344.
Pełny tekst źródłaKulkarni, Aditya, Jianli Zhou, Kishor Bhatia i Panna Sharma. "Tumor sensitization to PARP inhibitors by DNA damaging synthetically lethal acylfulvenes." Journal of Clinical Oncology 41, nr 16_suppl (1.06.2023): e15123-e15123. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e15123.
Pełny tekst źródłaDeCuypere, Michael, Melissa LoPresti, Hinda Najem, Shashwat Tripathi, Joanne Xiu, Hilary Seifert, Valerie I. Brown i in. "Vulnerability to immune therapy in BRAF- and MYB-altered pediatric gliomas." Journal of Clinical Oncology 41, nr 16_suppl (1.06.2023): 2066. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.2066.
Pełny tekst źródłaJamshidi, Pouya, Kristyn Galbraith, Matthew Mccord, Lucas Santana-Santos, Lawrence Jennings, Matija Snuderl i Craig Horbinski. "PATH-44. VARIANT ALLELIC FREQUENCY OF DRIVER MUTATIONS PREDICTS SUCCESS OF GENOMIC METHYLATION CLASSIFICATION IN CNS TUMORS". Neuro-Oncology 24, Supplement_7 (1.11.2022): vii160. http://dx.doi.org/10.1093/neuonc/noac209.617.
Pełny tekst źródłaDeStefanis, Rebecca A., Autumn M. Olson, Alyssa K. DeZeeuw, Susan N. Payne, Cheri A. Pasch, Linda Clipson i Dustin A. Deming. "Abstract 1128: MTORC1/2 and HDAC1/2 inhibition promote tumor response through inhibition of MYC". Cancer Research 82, nr 12_Supplement (15.06.2022): 1128. http://dx.doi.org/10.1158/1538-7445.am2022-1128.
Pełny tekst źródłaArsyad, Nur Rohmah, Risanto Siswosudarmo i Ardhanu Kusumanto. "Hubungan antara Ekspresi P53 Mutan terhadap Operabilitas Kanker Serviks Stadium IIB Pasca Kemoterapi Neoajuvan". Jurnal Kesehatan Reproduksi 7, nr 1 (14.05.2020): 49. http://dx.doi.org/10.22146/jkr.53838.
Pełny tekst źródła